IL1B and Parkinson disease: Based on the literature and clinical studies shown in table 1, this review will highlight key cytokines that can modulate pro-inflammatory (TNFα, IL-6 and IL-1β) and anti-inflammatory (IL-10, IL-4 and IL-1RA) signalling pathways that may contribute to PD pathology.